← ScholarPulse
HomeStudies

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer is one of 9,000 studies in the ScholarPulse dataset. Key details — Authors: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson; Journal / source: New England Journal of Medicine; Year: 2005.

AuthorsEdward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson
Journal / sourceNew England Journal of Medicine
Year2005
FieldHER2/EGFR in Cancer Research
Times cited5352
Typearticle
DOI / linkhttps://doi.org/10.1056/nejmoa052122

🔍 Search all studies →